DNB Asset Management AS Boosts Holdings in Intuitive Surgical, Inc. $ISRG

DNB Asset Management AS boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 249,861 shares of the medical equipment provider’s stock after purchasing an additional 50,854 shares during the quarter. DNB Asset Management AS’s holdings in Intuitive Surgical were worth $111,745,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Tobam grew its holdings in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at approximately $27,000. Guerra Advisors Inc purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $37,000. Finally, Riggs Asset Managment Co. Inc. boosted its stake in Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 32 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Up 0.1%

Intuitive Surgical stock opened at $506.88 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The company has a market cap of $180.01 billion, a P/E ratio of 64.24, a P/E/G ratio of 3.90 and a beta of 1.65. The business has a 50-day simple moving average of $531.21 and a two-hundred day simple moving average of $511.26.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter last year, the firm posted $2.21 earnings per share. The firm’s revenue was up 18.8% compared to the same quarter last year. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 421 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the completion of the sale, the executive vice president directly owned 409 shares in the company, valued at $202,438.64. This represents a 50.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 56,189 shares of company stock valued at $30,785,441. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Raymond James Financial boosted their target price on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Barclays set a $712.00 price target on shares of Intuitive Surgical and gave the company an “overweight” rating in a report on Monday, January 26th. HSBC lifted their price target on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research note on Monday, January 26th. Finally, Evercore lowered their price objective on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research report on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.86.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.